Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. HON
4. KBH
5. MRK
6. HTZ
7. INFY
8. HONA
9. TTWO
10. QCOM

Go back to Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates

Madrigal Pharma (MDGL) Tops Q2 EPS by $1.73, Beats on Revenue

August 5, 2025 7:06 AM EDT

Madrigal Pharma (NASDAQ: MDGL) reported Q2 EPS of ($1.90), $1.73 better than the analyst estimate of ($3.63). Revenue for the quarter came in at $212.8 million versus the consensus estimate of $159.45 million.

For earnings history and earnings-related data on Madrigal Pharma (MDGL) click here.

... More